All
Results: 34201-34212 of 69186

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.

In Davos, Ambipar and the Ministry of Indigenous Peoples sign a Protocol of Intent aimed at climate emergencies and sustainability






